Latest News about AZN
Recent news which mentions AZN
Innate Pharma Says Chemo-Free Monalizumab Triplet Therapy Shows Preliminary Anti-Cancer Activity
December 09, 2021
From Benzinga
AstraZeneca's COVID-19 Therapy Wins FDA Approval As First Antibody To Prevent Infection In Immunocompromised
December 09, 2021
From Benzinga
The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO
December 09, 2021
From Benzinga
Why Novavax Stock Is Soaring Today
December 07, 2021
From Motley Fool
Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response
December 07, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
December 07, 2021
From Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
Ionis, AstraZeneca Ink Licensing Pact For Eplontersen In Protein Misfolding Disorder
December 07, 2021
From Benzinga
From Benzinga
Johnson & Johnson Booster COVID-19 Shot Shows Encouraging Action After Pfizer/BioNTech Jab
December 06, 2021
From Benzinga
Here's Why AstraZeneca Stock Could Help Make You Rich
December 04, 2021
Tickers
AZN
From Motley Fool
From Motley Fool
From Benzinga
A new study finds that most COVID-19 vaccines boost immunity, though there is no winning shot
December 03, 2021
From MarketWatch
WHO has not seen any reports of deaths caused by omicron variant, urges people not to panic as delta still dominant
December 03, 2021
From MarketWatch
The Implications Behind Genetron Health's Latest Earnings Report
December 03, 2021
From Benzinga
AstraZeneca Blocks SOBI's $8B Buyout, Advent Withdraws The Bid - Report
December 03, 2021
From Benzinga
From Benzinga
Is High Pressure Good for Drug Development?
December 02, 2021
From Benzinga
Breakthrough Cancer Therapy? This Biotech Shares Preclinical Data and Ambitious Plans
December 02, 2021
From Benzinga
From Motley Fool
Have the Markets Overreacted to Omicron?
November 30, 2021
From InvestorPlace
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
From InvestorPlace
Why Shares of Genetron Holdings Are Up More than 9.3% on Tuesday
November 30, 2021
From Motley Fool
The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout
November 30, 2021
From Benzinga
From Benzinga
Novavax Is a Buy Based on Its Outlook, But Not for the Long Haul
November 29, 2021
From InvestorPlace
From Benzinga
These Biotech Companies Are Attempting to Use Improved Antibody Technology in the Fight To Eradicate COVID-19
November 29, 2021
From Benzinga
Got $5,000? These 2 Stocks Could Be Bargain Buys in 2022
November 27, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.